Skip to main content
OpenTrials
Completed

NCT Number: NCT06905574

Surgeon-Guided Serratus Block in Breast Reduction Surgery

Surgeon guided serratus block, which can be performed by the surgeon in participants undergoing breast reduction surgery, may reduce the sensation of pain from the surgical field in the postoperative period. Thus, participants experience less pain in the postoperative period, consume less analgesics, and there is a decrease in related complications. The aim of this study was to evaluate the effects of the intraoperative surgeon guided serratus block applied on the analgesic consumption of the participants in the first 24 hours after surgery in participants undergoing breast reduction surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Control Breast Reduction

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Samsun training and research hospital

Samsun, 55020, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient's willingness to be included in the study
  • 18-65 years
  • Woman
  • Operated with inferior pedicled breast reduction technique
  • The distance from the sternal notch to the nipple complex is between 25-40cm
  • ASA I-II
  • Breast Usg result BIRADS 1-2
  • Patients who have not previously received RT to the breast and have no history of malignancy

Exclusion criteria

  • Patient's request/refusal not to be included in the study
  • Previous history of malignancy
  • RT story,
  • ASA 3-4-5-patient group
  • Severe organ failure
  • Alcohol, drug addiction
  • Bupivacaine allergy
  • Diagnosis of psychiatric illness and psychiatric drug use
  • Surgery lasting longer than 3 hours
  • Bleeding diathesis

Treatment and study plan

surgeon guided serratus block

Other

Surgeon guided Serratus Block will be applied before closing dermoglandular flaps

Primary outcomes

  1. 24 hours postoperatively opioid consumption

    Time frame: 24 hours

    In the postoperative period, patients will be given opioids according to their pain density with a patient-controlled device, and the daily Morphine consumption in Patient Controlled Analgesia device will be collected and compared between groups.

Secondary outcomes

  1. post-operative acute pain status, post-operative nausea-vomiting status, post-operative NRS determination of pain at rest and in motion determination of complications such as nausea, vomiting, itching, determination of the first PCA analgesic request.

    Time frame: 24 hours

    Changes in the Numerical Rating Scale (NRS) will be recorded at rest and during movement. The participant's baseline NRS will be recorded, followed by measurements before and after neuraxial positioning and up to 24 hours post-surgery. The NRS is a unidimensional measure of pain intensity in adults. The 11-point numerical scale ranges from '0' representing one end of the pain spectrum (e.g. 'no pain') to '10' representing the other end (e.g. 'worst imaginable pain').

Sponsors and collaborators

Lead sponsor

alperen can kokten

Other

Registry information

Official study title

Postoperative Analgesic Efficacy of Intraoperative Surgeon-Guided Serratus Block: A Prospective Randomized Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 1, 2025
Registry last updated
Jan 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.